Skip to content

Cardinal Health CAH Total Equity

Total Equity at other companies

Eli Lilly logo
Eli LillyLLY
$31.2B+97.9%
McKesson logo
McKessonMCK
-$2.17B-4.7%
Cencora logo
CencoraCOR
$3.4B+235%
AbbVie logo
AbbVieABBV
-$6.66B-569%
Avanos Medical logo
Avanos MedicalAVNS
$782.1M-6.8%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$45.41M+65.5%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$55.72B+42.2%
Enterprise value$60.7B+35.3%
P/E35.8×+10.7×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's total equity?
Cardinal Health (CAH) reported total equity of -$2.83B in Q1 2026.
How has Cardinal Health's total equity changed year-over-year?
Cardinal Health's total equity increased by 3.9% year-over-year, from -$2.95B to -$2.83B.
What is the long-term trend for Cardinal Health's total equity?
Over 4 years (2021 to 2025), Cardinal Health's total equity has grown at a 11.6% compound annual growth rate (CAGR), from $1.79B to -$2.78B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.